O B J E C T I V E S To evaluate the accuracy of adenosine myocardial contrast echocardiography (MCE) in diagnosing coronary artery disease (CAD).
D
efining the presence and functional significance of coronary artery stenosis is of critical importance in the management of patients with coronary artery disease (CAD). Owing to the invasive and costly nature of coronary angiography, there is a compelling need for reliable, noninvasive techniques for the purpose of diagnosis and risk stratification.
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The diagnostic and prognostic roles of perfusion imaging with single-photon emission computed tomography (SPECT) and cardiac magnetic resonance (CMR) are well established (1) (2) (3) (4) (5) . Because perfusion deficits arise early in the ischemic cascade, the induction and detection of perfusion defects with both of these imaging modalities constitute a safe and sensitive means for detecting CAD (6) . Compared with SPECT, key advantages of CMR include its superior spatial resolution and the avoidance of exposure to ionizing radiation (7) . Moreover, the performance of CMR perfusion imaging may be further augmented with the use of higher field strengths or by a multiparametric approach incorporating late gadolinium enhancement imaging (8, 9 ).
An alternative to perfusion imaging techniques is wall motion imaging, such as dobutamine stress echocardiography (10) . The diagnostic and prognostic roles of this technique are also well documented (11, 12) . However, because contractile dysfunction occurs later in the ischemic cascade, pharmacologic induction of wall motion abnormality presents greater hazard to the patient and results in severe adverse effects in a minority of patients (13) .
The recent advent of second-generation ultrasound microbubble contrast agents now enables perfusion imaging with echocardiography (14, 15) .
Advantages of this technique include high spatial and temporal resolution, in addition to the wide availability and portability of echocardiography. Myocardial contrast echocardiography (MCE) using dipyridamole has been evaluated in recent trials, suggesting performance equivalent to or even superior to that of SPECT imaging (14, 16) . Adenosine is an alternative pharmacologic stressor, whose diagnostic role and excellent safety profile are already well documented in SPECT and CMR perfusion imaging (1) (2) (3) (4) (17) (18) (19) . Yet, compared with dipyridamole, adenosine has the key advantage of a shorter half-life, which minimizes adverse effects and facilitates a more time-efficient examination. Perfusion imaging with adenosine is a relatively new application, and the use of contrast for this purpose has yet to receive approval. Previous studies evaluating adenosine MCE are few in number and of small size, and methodologic limitations leave unresolved the question of the clinical utility of this technique (20 -26) .
We hypothesized that a simplified adenosine MCE protocol could form the basis of a rapid but accurate diagnostic test for CAD in the clinical setting. Accordingly, we prospectively evaluated its accuracy in identifying the presence and functional significance of CAD. As reference standards, we used 1) diagnostic coronary angiography to define anatomic CAD and 2) high field-strength, multiparametric CMR imaging to determine the functional significance of CAD.
M E T H O D S
Patient population. We prospectively recruited 65 patients, 18 to 80 years of age, who had been referred to the regional tertiary center for elective diagnostic angiography as part of routine clinical care for further investigation of exertional chest pain. Exclusion criteria were recent myocardial infarction (within 7 days) and contraindications to CMR (severe claustrophobia, metallic implants/ foreign bodies), adenosine (second-/third-degree atrioventricular block, obstructive pulmonary disease, dipyridamole use), gadolinium (anaphylaxis, estimated glomerular filtration rate Ͻ60 ml/min), and sulfur hexafluoride (previous allergic reaction). The CMR and MCE examinations were undertaken on the same day, in random order. Patients were asked to avoid caffeine for 24 h before their examinations, but routine antianginal medications were continued. The study was conducted according to the Declaration of Helsinki and was approved by the regional ethics committee. All participants gave written informed consent before participation. Echocardiography protocol. Each patient underwent MCE examination (IE33, Philips Ultrasound, Andover, Massachusetts) using an S3 transducer and the preset low mechanical index (MI) imaging in power modulation mode (operating frequency 2.5 MHz). The default MI was 0.10, with small variation (0.09 to 0.15) according to the imaging depth. A peripheral infusion of sulfur hexafluoride (Sonovue, Bracco Diagnostics Inc., Milan, Italy) was commenced at 0.7 ml/min and adjusted in 0.1-ml/min steps to achieve optimum myocardial opacification. Optimum myocardial opacification was defined as homogeneous left ventricular opacification combined with at least mild homogeneous opacification of myocardial segments without attenuation or shadow artifacts. Once "steady state" was reached, resting images were acquired in the 3 apical long-axis views. Single-beat loops were acquired during short breath holds and were stored digitally. For stress imaging, intravenous adenosine (140 g/kg/min) was administered for 4 minutes, or less if angina was induced or if perfusion/wall motion abnormalities became apparent. During the infusion, the same imaging dataset (comprising 2-, 3-, and 4-chamber apical views) was sequentially acquired at approximately 1-min intervals, with storage of multiple cineloops for each view. Patients were monitored continuously by electrocardiography, sphygmomanometry, and pulse oximetry. CMR protocol. The CMR examination at 3-T (Trio, Siemens Medical Solutions, Malvern, Pennsylvania) was performed using anterior and posterior phased-array coils. From standard piloting, shortaxis cine images covering the left ventricle were acquired using an electrocardiography (ECG)-gated steady-state free precession sequence (echo time 1.5 ms, repetition time 3 ms, flip angle 60 o , slice thickness 7 mm, slice gap 3 mm). Offresonance artifacts were minimized by shim adjustments and changes in synthesizer frequency.
For CMR perfusion imaging, patients were monitored continuously by ECG, sphygmomanometry, and pulse oximetry. After 4 min of intravenous adenosine (140 g/kg/min), or fewer if angina was induced, a 0.05-mmol/kg bolus of gadolinium-based contrast (gadodiamide, Omniscan, GE Healthcare, Princeton, New Jersey) was injected, followed by 15 ml of normal saline at a rate of 6 ml/s. During the first pass of contrast, 3 to 4 short-axis images were acquired every cardiac cycle using an ECG-gated T 1 -weighted fast gradient echo sequence with generalized autocalibrating partially parallel acquisitions reconstruction (echo time 1.04 ms, repetition time 2 ms, saturation recovery time 100 ms, voxel size 2.1 ϫ 2.6 ϫ 8 mm 3 , flip angle 17 o , slice thickness 8 mm). During imaging, patients were instructed to hold their breath as long as possible in end-expiration. After 20 min, the same sequence was repeated without adenosine for resting perfusion.
For late gadolinium enhancement (LGE) imaging, following a further bolus of gadodiamide (0.05 mmol/kg) and after a 5-min delay, images were acquired in 3 long-axis and all short-axis planes, using a T 1 -weighted segmented inversion-recovery turbo fast low-angle shot sequence (echo time 4.8 ms, voxel size 1.4 ϫ 2.4 ϫ 8 mm 3 , flip angle 20°, slice thickness 8 mm). The inversion time was adjusted to obtain optimal nulling of noninfarcted myocardium. Coronary angiography. Within 2 weeks of the CMR and MCE examinations, all patients underwent coronary angiography using standard techniques. Images of the coronary arteries were obtained in multiple projections, avoiding overlap of side branches and foreshortening of relevant coronary stenoses. Echocardiography analysis. Echocardiography scans were visually interpreted in random order by a single observer blinded to clinical information, angiographic data, and CMR results. Assessment of wall motion and perfusion was performed using the 17-segment American Heart Association model (27) . For wall motion assessment, standard segmental scoring was performed (1 ϭ normal, 2 ϭ hypokinesis, 3 ϭ akinesis, 4 ϭ dyskinesis), with documentation of progression of wall motion abnormality during stress. For perfusion assessment, rest and stress images were displayed side by side. A perfusion defect was defined as a decrease in contrast enhancement relative to another region with comparable image quality. Perfusion defects were considered artifactual if there were attenuation defects, contrast shadowing, or artifacts from external shadowing. Inducible ischemia was defined as a stress perfusion defect appearing more extensive than at rest, or progression of resting wall motion abnormality. The diagnosis of CAD was determined by the presence of 1) resting akinesis; 2) reversible wall motion abnormalities; or 3) perfusion defects (fixed or reversible). Ischemia was defined as the presence of reversible regional wall motion abnormalities or reversible perfusion defects. For the identification of disease location, a positive diagnosis was determined by the presence of perfusion/wall motion abnormality in any segment ascribed to a coronary artery according to standardized criteria (27) . The assessment of CAD severity was determined according to whether single-vessel and multivessel disease were classified correctly. The overall diagnosis of CAD, on a per patient basis, was determined by the presence of any abnormal segment. Interobserver agreement. To assess interobserver agreement, all MCE images were interpreted by a second blinded reader. Interobserver agreement was assessed on per-patient and per-vessel bases. For CMR and diagnostic angiography, interobserver agreement per vessel was also assessed. CMR analysis. CMR scans were visually interpreted in random order by a single blinded reader with assessment of resting wall motion, LGE, and perfusion on separate days. Perfusion and LGE data were subsequently combined according to the algorithm described by Klem et al. (9) .
For perfusion assessment, stress and rest perfusion scans were magnified and displayed simultaneously and analyzed using criteria previously described (8) . For resting wall motion assessment, standard segmental scoring was performed (1 ϭ normal, 2 ϭ hypokinesis, 3 ϭ akinesis, 4 ϭ dyskinesis). For LGE assessment, segments were graded as abnormal or normal. The diagnosis of CAD was determined on a segmental basis by the presence of either perfusion abnormalities or LGE (9) . For MCE analysis, a segmental approach was used to determine CAD severity and location. The functional significance of coronary stenosis was determined by concurrent analysis of perfusion and LGE images; ischemia was defined as stress perfusion defects more extensive than resting perfusion defects/LGE. Angiographic analysis. Quantitative coronary angiography was performed by a single blinded reader. Each myocardial segment was ascribed a coronary artery territory according to standard criteria (27) . Diameters of reference and stenotic coronary arteries were measured by a computer-assisted quantitative method (Axiom Artis QCA software, Siemens). The contrastfilled catheter was used for image magnification calibration. Significant CAD was defined angiographically as Ն50% stenosis in any epicardial coronary artery/branch with diameter Ն2 mm.
Statistical analysis. Data analysis was performed using Medcalc 9.1.0.1 (Medcalc, Mariakerke, Belgium). Discrete data were compared using McNemar tests and chi-square or Fisher exact test as appropriate.
R E S U L T S
Study population. From a total of 99 consecutive patients screened, 65 elected to participate in the study. Two patients did not undergo CMR examination owing to claustrophobia, and one subsequently withdrew consent; thus, 62 patients completed both scans and were included in the final analysis. Baseline patient characteristics are outlined in Table 1 .
In total, 41 of 62 patients (66%) had angiographically defined stenosis Ն50% (mean diameter stenosis Ϯ SD 74 Ϯ 20%) and 29 of 62 (47%) had Ն70% stenosis. Of the whole cohort, 21 of 62 (34%) had single-vessel and 20 of 62 (32%) had multivessel disease. Thirty-one patients (50%) had significant Values are n (%) or mean Ϯ SD. ACE ϭ angiotensin-converting enzyme; BMI ϭ body mass index; CAD ϭ coronary artery disease; LGE ϭ late gadolinium enhancement. No significant adverse events occurred during either scan, and no clinical cardiac events occurred in the period between the scans and coronary angiography (median interval 7 days; interquartile range 6 to 14 days). Image analysis and quality. For MCE, no patient was excluded owing to inadequate imaging windows. All wall motion images were deemed satisfactory, but perfusion images were suboptimal in 1 scan. All CMR perfusion images were of sufficient quality for analysis, and no images were excluded.
Detection of anatomically significant CAD by MCE.
Using quantitative coronary angiography as the reference standard for determining the presence of CAD, MCE achieved a diagnostic accuracy of 82%, with sensitivity of 85% and specificity of 76%. Disease location was also identified with good accuracy (diagnostic accuracy 81% for left anterior descending disease, 77% for left circumflex disease, and 84% for right coronary artery disease). Table 2 demonstrates that the success of MCE was chiefly due to the high sensitivity of perfusion assessment (76%); the addition of stress wall motion to perfusion resulted in a further increase in sensitivity but a marginal decrease in specificity.
To gauge the performance of MCE against another noninvasive test, we evaluated the ability of CMR imaging (using combined perfusion/LGE assessment) to identify angiographically significant disease. Perfusion imaging with CMR achieved high sensitivity, albeit with low specificity, but the latter was augmented by the addition of LGE assessment (sensitivity for the combined assessment 90%, specificity 81% [ Table 2 ]). When compared with CMR, MCE achieved comparable results for the overall detection of CAD (diagnostic accuracy 87% for CMR vs. 82% for MCE, p ϭ 0.61; sensitivity 90% vs. 85%, p ϭ 0.73; and specificity 81% vs. 76%, p ϭ 1.00). Similarly, as illustrated in Table 3 , there were no significant differences in the diagnostic accuracy of the 2 techniques in identifying the extent and distribution of CAD. Figures 1  and 2 depict patient examples from the study. Detection of inducible ischemia by MCE. Inducible ischemia was identified by CMR in 11.0% of segments and by MCE in 7.4% of segments (p ϭ 0.006). Using CMR imaging as the reference standard for functional assessment, MCE achieved sensitivity of 85% and specificity of 74%, with diagnostic accuracy of 79%. On a per-vessel basis, MCE correctly identified 76% of CMR-defined ischemic territories and 89% of normal territories (diagnostic accuracy 87%). In territories subtended by intermediate-grade stenosis (50% to 69%), MCE correctly identified 67% of those with ischemia and 84% of those without ischemia (diagnostic accuracy 77%). Interobserver variability. For the overall diagnosis of CAD, on a per-patient basis, the interobserver agreement for MCE was 79% (95% confidence intervals [CI] 67% to 88%). On a per-vessel basis, interobserver agreement was 81% (95% CI 75% to 87%). Complete results for both observers are listed in Table 4 . On a per-vessel basis, interobserver agreement for CMR was 82% (95% CI: 75% to 87%) and for diagnostic angiography was 96% (95% CI: 92% to 98%). LGE-CMR 48% (30%-67%) 85% (68%-95%) 68% (55%-79%)
Proportions expressed as percentage (95% confidence intervals). CMR ϭ cardiac magnetic resonance; MCE ϭ myocardial contrast echocardiography; other abbreviations as in Table 1 .
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D I S C U S S I O N
The principal finding in this prospective study is that adenosine MCE identifies coronary stenosis and its functional significance with favorable diagnostic accuracy. Moreover, the performance of MCE in detecting significant anatomic disease is comparable with that of high field-strength, multiparametric CMR. Notably, adenosine MCE is a simple bedside investigation which can be performed within 10 min, highlighting the potential utility of this technique in the clinical setting.
In the last decade, refinements in ultrasound technology and contrast media have expanded the role of echocardiography in the assessment of CAD (15) . Whereas harmonic imaging causes destruction of contrast agents, newer techniques such as power modulation and power pulse inversion, which use a low MI, permit real-time perfusion imaging (15) . Improved endocardial border delineation with contrast also facilitates the detection of subtle wall motion abnormalities and is advantageous during stress, owing to difficulties posed by cardiac and respiratory mo- tion. Furthermore, interobserver agreement is significantly greater with contrast-enhanced than with unenhanced echocardiography (28) . However, despite the benefits of contrast, perfusion imaging remains operator dependent, for both performance and interpretation of studies, and may be affected by image attenuation and the availability of suitable acoustic windows. The utility of adenosine MCE using secondgeneration contrast media has been compared with SPECT imaging in a number of studies, suggesting equivalent or superior diagnostic accuracy (20 -25) .
Figure 1. Examples Showing CMR and MCE Studies
Case 1 (LAD and LCx disease): short-axis CMR images show absent LGE but stress perfusion defects in the septum (arrowheads) and lateral wall (arrows). Corresponding long-axis MCE images demonstrate reversible perfusion defect and wall motion abnormality in the septum, apex, and lateral wall (arrows). Case 2 (proximal LAD stenosis): short-axis CMR images show anterior LGE and corresponding perfusion defect (arrows); long axis 2-chamber MCE images show apical akinesis at rest and anteroapical stress perfusion defect (arrows). CMR ϭ cardiac magnetic resonance; LAD ϭ left anterior descending; LCx ϭ left circumflex; LGE ϭ late gadolinium enhancement; MCE ϭ myocardial contrast echocardiography.
Figure 2. More Examples Showing CMR and MCE Studies
Case 3 (no significant CAD): short-axis CMR images show absent LGE and homogeneous uptake of gadolinium. Corresponding long-axis MCE images demonstrate normal perfusion at rest and at stress. Case 4 (RCA stenosis): short-axis CMR images show inferior wall LGE with corresponding perfusion defect (arrowheads), and corresponding MCE images show inferior wall perfusion defect and wall motion abnormality both at rest (arrowheads) and at stress (arrows). CAD ϭ coronary artery disease; RCA ϭ right coronary artery; other abbreviations as in Figure 1 .
These studies reported 76% to 92% concordance with SPECT by territory, which is comparable to the 79% found in our study involving CMR (20, (22) (23) (24) . Similarly, studies comparing MCE with coronary angiography have reported 71% to 92% diagnostic accuracy as compared with 82% in our study (20,21,24 -26) . However, many of these earlier studies did not undertake angiography in all patients, or included populations with a high prevalence of CAD or select patient groups (e.g., acute coronary syndromes, left bundle branch block, hypertension) (20 -26) . Only one of these studies incorporated wall motion assessment in addition to perfusion, and 94% of subjects had CAD in this study (26) . In our study, we assessed both wall motion and perfusion with adenosine MCE, and to our knowledge, this is the first systematic study to compare MCE with CMR. In contrast to previous studies, a major strength of our study is the intermediate prevalence of CAD in our cohort (significant coronary stenosis in 66% and inducible ischemia in 44%). We minimized referral bias by excluding patients with a high pre-test probability of CAD (e.g., patients with an established diagnosis of coronary artery stenosis) and subjects with low pre-test probability (e.g., normal volunteers or individuals with previously normal angiography), which may artificially distort sensitivity or specificity.
Previous studies investigating the role of CMR perfusion (predominantly at 1.5-T) have substantiated its diagnostic utility (4) . Advantages of CMR imaging include its multiparametric nature (allowing for the concurrent measurement of function, anatomy, and viability together with perfusion), its high spatial resolution, and its capability for complete coverage of the heart. However, perfusion imaging with CMR can be adversely affected by the presence of artifacts because of susceptibility differences, motion, and arrhythmia. Klem et al. (9) showed that a multiparametric approach combining both perfusion and LGE imaging in a visual interpretation algorithm further augments the diagnostic accuracy of CMR perfusion imaging. Recent work has also confirmed the superiority of higher field strengths (3-T vs. 1.5-T), by virtue of increased signal-to-noise and contrast-to-noise ratios (8) . The CMR results of our study confirm the findings of Klem et al. (9) that LGE imaging augments the diagnostic capacity of perfusion imaging alone, by facilitating the differentiation of true perfusion defects from artifacts. However, in our study, as may be expected with the higher field strength, we report greater sensitivity for perfusion imaging at 3-T.
Study limitations. Although X-ray angiography was used as the gold standard for determining the significance of coronary artery stenosis, correlation between endoluminal appearances and ischemia is imprecise, particularly in the presence of collateralization or microvascular dysfunction. Moreover, owing to interindividual variation, standardized segmentation does not necessarily correlate with coronary territory. Our study involved exclusively patients referred for diagnostic angiography; therefore, the findings in this study may not necessarily apply to populations with a lower pretest probability of disease. Quantitative MCE or CMR analysis was not employed in this study; although potentially Abbreviations as in Table 3 .
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Another potential limitation in our study is that we used sulfur hexafluoride instead of the more widely available contrast agents perflutren proteintype A microspheres injectable suspension (Optison) and perflutren liquid microspheres injectable suspension (Definity) because the latter were unavailable in the United Kingdom when the study was commenced. We anticipate that the use of alternative microbubble contrast agents in conjunction with adenosine will generate comparable results because these agents have been used effectively for perfusion imaging with other stressors (29) . However, this hypothesis requires formal testing, ideally in a large, multicenter study.
In our study, we chose not to use the flash replenishment technique. Theoretically, the use of flash replenishment may have enhanced sensitivity, particularly for the detection of intermediate-grade stenoses and in the identification of multivessel disease. Although previous studies have raised concerns about the safety of this technique, a recent large series confirmed the safe use of flash replenishment (30 -33) . Nevertheless, an important goal in our study was to develop a rapid screening test, to facilitate workflow in the clinical environment while achieving favorable patient tolerability. Although flash replenishment is readily applicable with dipyridamole MCE, this technique is less suited to the shorter adenosine protocol. Yet, in our study, we are encouraged by the achievement, even without flash replenishment, of diagnostic performance comparable to that of high field-strength CMR. A pragmatic approach in future studies may be to employ flash replenishment in selected cases, if no abnormality is initially detected on steady-state imaging.
C O N C L U S I O N S
In conclusion, we have demonstrated the favorable diagnostic performance of a simplified adenosine MCE protocol in identifying both the presence of coronary stenosis and its functional significance. Moreover, the performance of MCE in diagnosing significant anatomic disease is comparable to that of high field-strength CMR imaging. The results of our small pilot study warrant further confirmation in larger, multicenter studies. If realized, adenosine MCE could be added to the diagnostic armamentarium as a useful clinical screening test, combining the favorable diagnostic performance and safety profile of adenosine with the simplicity and bedside convenience of transthoracic echocardiography.
